Comparison of viral RNA copies in plasma and HIV-DNA copies in the spleen, BM, and thymus from hNOG mice receiving low- and high-dose viral inoculations
| Mouse ID no. . | HIV strain . | TCID50 . | Time after inoculation, d . | RNA viral copies/mL . | CD4/CD8 ratio . | HIV-DNA copies/106 human cells . | ||
|---|---|---|---|---|---|---|---|---|
| Splee . | BM . | Thymus . | ||||||
| Low-dose viral inoculation group | ||||||||
| 113-1 | HIV-1JRCSF | 200 | 18 | 6 240 | 1.8 | 34 177 | 11 785 | 3 495 |
| 112-2 | HIV-1JRCSF | 200 | 18 | <500 | 1.2 | < 100 | < 100 | < 100 |
| 113-2 | HIV-1JRCSF | 200 | 40 | 6 177 | 1.6 | 25 855 | 27 920 | 3 473 |
| 112-3 | HIV-1JRCSF | 200 | 40 | <500 | 0.9 | < 100 | < 100 | <100 |
| 112-4 | HIV-1MNp | 180 | 18 | 72 477 | 1.3 | 18 873 | 100 | ND |
| 113-4 | HIV-1MNp | 180 | 40 | 70 667 | 0.3 | 4 947 | 653 | 32 163 |
| 112-1 | HIV-1MNp | 180 | 40 | <500 | 0.9 | < 100 | < 100 | < 100 |
| High-dose viral inoculation group | ||||||||
| 136-3 | HIV-1JRCSF | 65 000 | 25 | 252 381 | 0.8 | 958 871 | 1 797 600 | 232 155 |
| 136-2 | HIV-1JRCSF | 65 000 | 29 | 50 167 | 0.7 | 41 172 | 54 521 | 8 600 |
| 141-1 | HIV-1JRCSF | 65 000 | 30 | 67 667 | 2.2 | 27 735 | 52 430 | 429 |
| 161-3 | HIV-1JRCSF | 65 000 | 30 | 13 847 | 0.9 | 104 466 | 14 653 | 111 080 |
| 157-3 | HIV-1MNp | 20 000 | 31 | 1 253 925 | 0.5 | 41 053 | 56 802 | 976 556 |
| 157-4 | HIV-1MNp | 20 000 | 31 | 147 973 | 0.6 | 3 634 | 262 | 40 796 |
| 161-6 | HIV-1MNp | 20 000 | 31 | 108 073 | 1.7 | 4 991 | < 100 | 3 673 |
| Mouse ID no. . | HIV strain . | TCID50 . | Time after inoculation, d . | RNA viral copies/mL . | CD4/CD8 ratio . | HIV-DNA copies/106 human cells . | ||
|---|---|---|---|---|---|---|---|---|
| Splee . | BM . | Thymus . | ||||||
| Low-dose viral inoculation group | ||||||||
| 113-1 | HIV-1JRCSF | 200 | 18 | 6 240 | 1.8 | 34 177 | 11 785 | 3 495 |
| 112-2 | HIV-1JRCSF | 200 | 18 | <500 | 1.2 | < 100 | < 100 | < 100 |
| 113-2 | HIV-1JRCSF | 200 | 40 | 6 177 | 1.6 | 25 855 | 27 920 | 3 473 |
| 112-3 | HIV-1JRCSF | 200 | 40 | <500 | 0.9 | < 100 | < 100 | <100 |
| 112-4 | HIV-1MNp | 180 | 18 | 72 477 | 1.3 | 18 873 | 100 | ND |
| 113-4 | HIV-1MNp | 180 | 40 | 70 667 | 0.3 | 4 947 | 653 | 32 163 |
| 112-1 | HIV-1MNp | 180 | 40 | <500 | 0.9 | < 100 | < 100 | < 100 |
| High-dose viral inoculation group | ||||||||
| 136-3 | HIV-1JRCSF | 65 000 | 25 | 252 381 | 0.8 | 958 871 | 1 797 600 | 232 155 |
| 136-2 | HIV-1JRCSF | 65 000 | 29 | 50 167 | 0.7 | 41 172 | 54 521 | 8 600 |
| 141-1 | HIV-1JRCSF | 65 000 | 30 | 67 667 | 2.2 | 27 735 | 52 430 | 429 |
| 161-3 | HIV-1JRCSF | 65 000 | 30 | 13 847 | 0.9 | 104 466 | 14 653 | 111 080 |
| 157-3 | HIV-1MNp | 20 000 | 31 | 1 253 925 | 0.5 | 41 053 | 56 802 | 976 556 |
| 157-4 | HIV-1MNp | 20 000 | 31 | 147 973 | 0.6 | 3 634 | 262 | 40 796 |
| 161-6 | HIV-1MNp | 20 000 | 31 | 108 073 | 1.7 | 4 991 | < 100 | 3 673 |
Seven mice inoculated with a low infectious dose of HIV-1JRCSF (200 TCID50) or HIV-1MNp (180 TCID50), and 7 mice receiving a high infectious dose of HIV-1JRCSF (65 000 TCID50) or HIV-1MNp (20 000 TCID50) were listed.
ND indicates not done.